Intrinsic Value of S&P & Nasdaq Contact Us

Henry Schein, Inc. HSIC NASDAQ

NASDAQ Global Select • Healthcare • Medical - Distribution • US • USD

SharesGrow Score
51/100
1/7 Pass
SharesGrow Intrinsic Value
$147.54
+91.1%
Analyst Price Target
$90.17
+16.8%

Henry Schein, Inc. (HSIC) reported total assets of $11.22B and total liabilities of $6.42B for fiscal year 2025, resulting in total equity of $4.79B.

The company held $156M in cash and short-term investments. Total debt stood at $3.69B, with net debt of $3.53B. The Debt-to-Equity (D/E) ratio was 0.77 (moderate).

Current ratio is 1.38, suggesting adequate short-term liquidity. Interest coverage is 5.1x (adequate).

Criteria supported by this page:

  • HEALTH (50/100, Partial) — some metrics are adequate but not all reach ideal thresholds
  • MOAT (53/100) — Total assets $11.22B and equity $4.79B support the company's competitive scale
  • VALUE (48/100) — Debt-to-Equity 0.77 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 51/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
51/100
SG Score
View full scorecard →
~
VALUE
48/100
Price-to-Earnings & upside
→ Valuation
~
FUTURE
46/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
~
HEALTH
50/100
Debt-to-Equity & liquidity
Proven by this page
~
MOAT
53/100
→ Income
GROWTH
30/100
→ Income
INCOME
30/100
→ Income
Henry Schein, Inc. Balance Sheet History
Metric FY2025 FY2024 FY2023 FY2022
Total Assets $11.22B$10.22B$10.57B$8.61B
Total Liabilities $6.42B$5.38B$5.42B$3.94B
Total Debt $3.69B$2.87B$2.74B$1.5B
Cash & Investments $156M$122M$171M$117M
Total Stockholders Equity $3.25B$3.39B$3.66B$3.45B
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message